DÜŞÜK DOZ SİTARABİN (LD-ARAC)

Kaynaklar:

1- Klepin HD, Geiger AM, Tooze SB, Kritchevsky SB, Williamson JD, Pardee TS, et al. Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia. Blood. 2013;121:4287–94. doi: 10.1182/blood-2012-12-471680.

2- Winter JN, Variakojis D, Gaynor ER, Larson RA, Miller KB. Low-dose cytosine arabinoside (ara-C) therapy in the myelodysplastic syndromes and acute leukemia. Cancer. 1985;56:443–9.

3- Mufti GJ, Oscier DG, Hamblin TJ, Bell AJ. Low doses of cytarabine in the treatment of myelodysplastic syndrome and acute myeloid leukemia. N Engl J Med. 1983;309:1653–4.